CIK 0001682852
- Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813467528
- Phone
- +1 617-714-6500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $50,775,837
- in 5 filings, $50.8M under 10b5-1 plans
Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-12 | Bancel Stephane Chief Executive Officer | Grant or award | +13,233 | 5,500,297 | ||
| 2025-02-12 | Bancel Stephane Chief Executive Officer | Shares withheld for taxes | −6,400 | $30.93 | $198K | 5,493,897 |
| 2025-02-07 | Hoge Stephen President | Exercise or conversion 10b5-1 | +523 | 1,444,427 | ||
| 2025-02-07 | Hoge Stephen President | Shares withheld for taxes 10b5-1 | −281 | $33.61 | $9K | 1,444,146 |
| 2025-02-07 | Hoge Stephen President | Exercise or conversion · Restricted Stock Units 10b5-1 | −523 | 0 | ||
| 2025-01-03 | Mock James M Chief Financial Officer | Exercise or conversion 10b5-1 | +1,453 | 12,519 | ||
| 2025-01-03 | Mock James M Chief Financial Officer | Shares withheld for taxes 10b5-1 | −780 | $42.00 | $33K | 11,739 |
| 2025-01-03 | Mock James M Chief Financial Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −1,453 | 10,169 | ||
| 2024-12-09 | Klinger Shannon Thyme Chief Legal Officer | Sale 10b5-1 | −529 | $44.68 | $24K | 20,446 |
| 2024-12-06 | Klinger Shannon Thyme Chief Legal Officer | Exercise or conversion 10b5-1 | +1,138 | 20,975 | ||
| 2024-12-06 | Klinger Shannon Thyme Chief Legal Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −1,138 | 2,278 | ||
| 2024-12-05 | Mock James M Chief Financial Officer | Grant or award · Restricted Stock Units | +188,761 | 188,761 | ||
| 2024-12-05 | Klinger Shannon Thyme Chief Legal Officer | Grant or award · Restricted Stock Units | +188,761 | 188,761 | ||
| 2024-12-03 | Klinger Shannon Thyme Chief Legal Officer | Sale 10b5-1 | −112 | $43.30 | $5K | 19,837 |
| 2024-12-03 | Hoge Stephen President | Sale 10b5-1 | −314 | $43.30 | $14K | 1,443,904 |
| 2024-12-02 | Klinger Shannon Thyme Chief Legal Officer | Exercise or conversion 10b5-1 | +232 | 19,949 | ||
| 2024-12-02 | Klinger Shannon Thyme Chief Legal Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −232 | 1,164 | ||
| 2024-12-02 | Hoge Stephen President | Exercise or conversion 10b5-1 | +651 | 1,444,218 | ||
| 2024-12-02 | Hoge Stephen President | Exercise or conversion · Restricted Stock Units 10b5-1 | −651 | 3,259 | ||
| 2024-11-29 | Mock James M Chief Financial Officer | Sale 10b5-1 | −1,420 | $42.79 | $61K | 11,066 |
Page 21 of 38 · 743 trades